The lump may move easily within the breast tissue and may be tender to touch. Gynecomastia most often happens due to an imbalance of hormones — specifically testosterone and estrogen. Obesity can also cause an increase in breast size due to excess adipose (fat) tissue. Certain medications and medical conditions can also cause it. Regular self-examinations can help identify any changes in breast tissue early on. These causes of gynecomastia are natural and to be expected — they’re not physically harmful. Estrogen also suppresses the release of testosterone. You may be able to see this as a breast lump or feel it when you press on the area. It also binds to the androgen receptor, blocking the binding of T and DHT, or displacing them from their receptors. Type 2 causes include gonadotropins, clomiphene and enhanced endogenous estrogen, type 3 include metronidazole, cimetidine, flutamide, cyproterone acetate and bicalutamide. The role of PRL, progesterone and other growth factors (GFs) such as insulin like growth factor I (IGF-I) and epidermal growth factor (EGF), in the development of gynecomastia are unclear. It is recommended that physicians follow the algorithm for gynecomastia in patients under the age of 50 years, unless one of the atypical criteria shown in Figure 1 is met. In patients with pseudogynecomastia the fingers will not meet any resistance until they reach the nipple. In true cases of gynecomastia, the physician will feel a disc or firm tissue that is concentric with the nipple-areolar complex. These tumors influence hormonal levels, resulting in signs like gynecomastia. The use of alcohol, marijuana, and anabolic steroids can increase the risk of developing gynecomastia. After the tissue has become scarred, medications are not likely to be effective, and surgical removal is the only possible treatment. Gynecomastia, especially in pubertal males, often goes away on its own within about six months, so observation is preferred over specific treatment in many cases. During puberty, levels of these hormones may fluctuate and rise at different levels, resulting in a temporary state in which estrogen concentration is relatively high. Any condition or imbalance that disturbs the harmony of testosterone and oestrogen can also raise the likelihood of Gynaecomastia. In one nested case-control study of 41 Swedish men who developed breast cancer after treatment for prostate cancer, the risk was higher in candy96.fun men treated with oestrogen than in other survivors of prostate cancer.12 The risk of gynaecomastia and breast cancer coexists in high oestrogen states. We also referred to our institutional experience with gynaecomastia and male breast cancer. Although cancers are diagnosed in only about 1% of cases of male breast enlargement, practitioners may feel uncertain about how to differentiate gynaecomastia (benign breast enlargement) from malignancy and how to manage these disorders. Gynecomastia is the enlargement of male breast tissue caused by excessive growth of the breast gland. As men age, testosterone levels may naturally decline while estrogen levels remain relatively stable. There are several factors and conditions that can contribute to hormonal imbalances and thus trigger gynecomastia. Read further to learn the gynecomastia symptoms, risk factors, secondary prevention, and various gynecomastia treatments. It usually presents as a soft, symmetrical swelling of the breast tissue, which can sometimes be tender or painful. However, TRT not always effective and can sometimes worsen gynecomastia if the excess testosterone converted into estrogen. Importantly, there is also a growing body of evidence supporting the utility of this class of drugs in gynecomastia, particularly Tmx.21,22,23,24 Tmx is an estrogen antagonist, and is a well-tolerated, reliable and non-toxic agent. Although clinical data are limited, more studies have determined the efficacy of anti-estrogens compared with other gynecomastia therapies. Several agents regulate the hormonal imbalance that is thought to cause the gynecomastia. The duration of gynecomastia is a major factor affecting the initial approach to treatment. If gynecomastia is drug induced, symptoms may regress when the causative medication is stopped or changed.5,6,11 Systemic illness-related gynecomastia regresses with the treatment of these disorders (for example the treatment of hyperthyroidism, or surgical removal of testicular, adrenal, or other causative tumors may lead to regression). Before beginning treatment, the patient must be informed that these cases are usually benign and self-limiting and that over time fibrotic tissue replaces the symptomatic proliferation of glandular tissue, meaning that the pain and tenderness will resolve.